- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Lpath Inc+ Add to Watchlist
LPTN:US2.9100 USD 0.0100 0.34%
As of 20:10:00 ET on 12/18/2014.
Company Profile for Lpath Inc (LPTN)
Lpath, Inc. is a drug discovery company with a focus on bioactive signaling lipids as targets for treating and diagnosing human diseases.
Key Executives for Lpath Inc (LPTN)
|Michael LackInterim CEO||Gary J G AtkinsonSenior VP/CFO/Secretary|
|Dario A PaggiarinoSenior VP/Chief Dev Ofcr||Gary WoodnuttSenior VP:Research & Dev|